Green synthesized Moringa oleifera Leaf Powder – Silver Nanoparticles (MOLP-AgNPs) promotes apoptosis by targeting Caspase-3 and Phosphorylated-AKT signaling in MCF-7 cells

High mortality rates of breast cancer have been known as a significant health problem among women. As a widely consumed plant, Moringa oleifera contains many phytochemical constituents that can inhibit cancer cell activity. This study involves using Moringa oleifera to impede the development of canc...

Full description

Saved in:
Bibliographic Details
Main Authors: Happy Kurnia Permatasari, Sa'diyatul Rizqie Amaliyah Firdaus, Hendra Susanto, Nik Ahmad Nizam Nik Malek, Widodo, Holipah, Hikmawan Wahyu Sulistomo
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Journal of Agriculture and Food Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666154325000110
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:High mortality rates of breast cancer have been known as a significant health problem among women. As a widely consumed plant, Moringa oleifera contains many phytochemical constituents that can inhibit cancer cell activity. This study involves using Moringa oleifera to impede the development of cancer cells through green-based silver nanoparticle synthesis by targeting programmed cell death. Different analytical techniques were used to analyze the synthesized AgNPs, and it showed that MOLP-AgNPs have a spheroid form, and its surface plasmon resonance (SPR) was detected in the 476–478 nm range. Based on the total viable cells through dye exclusion assay, it showed that MOLP-AgNPs significantly reduced breast cancer cell viability, and there was no significant cytotoxic activity of MOLP-AgNPs against non-cancerous cells after 24 h investigation. Caspase-3 is an apoptosis-related protein and phosphorylated AKT, which plays a crucial role in cell growth and may interact with AgNPs indirectly. It was observed that MOLP-AgNPs promote apoptosis through Caspase-3-dependent signaling and inhibit AKT phosphorylation in a dose-dependent manner. These findings indicated that MOLP-AgNPs have the potential for further development as anticancer drugs, particularly for breast cancer.
ISSN:2666-1543